Abstract
Previous studies with direct-acting serotonin (5-HT) agonists and antagonists have demonstrated that stimulation of 5-HT1A, 5-HT1C and 5-HT2 receptors may promote cortisol and prolactin (PRL) secretion in man. There is also evidence that 5-HT1C/2 receptor stimulation contributes to the cortisol and PRL responses following administration of the 5-HT precursor, l-5-hydroxytryptophan (l-5-HTP), in man. To clarify the possible contribution of 5-HT1A receptor stimulation to the ability of l-5-HTP to stimulate cortisol and PRL secretion in man, the effect of pindolol, a beta adrenoceptor antagonist that is also a 5-HT1A partial agonist, on the l-5-HTP-induced increases in cortisol and PRL secretion, was examined in 12 normal male volunteers. Pretreatment with pindolol, 30 mg orally, significantly inhibited the PRL but not the cortisol response to l-5-HTP, 200 mg PO. Pindolol alone decreased basal plasma PRL levels and increased basal plasma cortisol levels, possibly due to 5-HT1A antagonist and agonists effects, respectively. These data, coupled with observations from other studies, suggest that the l-5-HTP-induced increase in PRL but not cortisol secretion requires 5-HT1A receptor activation. PRL secretion due to 5-HT formed from exogenous l-5-HTP may require the availability of both intact 5-HT1A and 5-HT2/5-HT1C receptors, since blockade of either receptor type inhibited the PRL response to l-5-HTP. The implication of this synergistic effect for interpretation of neuroendocrine studies involving the serotonergic system in man is discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 635-643 |
Number of pages | 9 |
Journal | Psychopharmacology |
Volume | 114 |
Issue number | 4 |
DOIs | |
State | Published - May 1994 |
Keywords
- 5-HT
- 5-HT and 5-HT receptors
- 5-Hydroxytryptophan
- Pindolol
- Prolactin Cortisol
ASJC Scopus subject areas
- Pharmacology